Sophia Genetics Sa Stock Probability of Future Stock Price Finishing Over 5.08

SOPH Stock  USD 5.08  0.17  3.24%   
Sophia Genetics' implied volatility is one of the determining factors in the pricing options written on Sophia Genetics SA. Implied volatility approximates the future value of Sophia Genetics based on the option's current value. Options with high implied volatility have higher premiums and can be used to hedge the downside of investing in Sophia Genetics SA over a specific time period. For example, SOPH260320C00005000 is a PUT option contract on Sophia Genetics' common stock with a strick price of 5.0 expiring on 2026-03-20. The contract was not traded in recent days and, as of today, has 50 days remaining before the expiration. The option is currently trading at a bid price of $0.6, and an ask price of $1.25. The implied volatility as of the 29th of January is 50.0. View All Sophia options

Closest to current price Sophia long PUT Option Payoff at Expiration

Sophia Genetics' future price is the expected price of Sophia Genetics instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Sophia Genetics SA performance during a given time horizon utilizing its historical volatility. Check out Sophia Genetics Backtesting, Sophia Genetics Valuation, Sophia Genetics Correlation, Sophia Genetics Hype Analysis, Sophia Genetics Volatility, Sophia Genetics History as well as Sophia Genetics Performance.
The Sophia Genetics' current Price Earnings To Growth Ratio is estimated to increase to 0.14, while Price To Sales Ratio is projected to decrease to 3.39. Please specify Sophia Genetics' target price for which you would like Sophia Genetics odds to be computed.

Sophia Genetics Target Price Odds to finish over 5.08

The tendency of Sophia Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 5.08 90 days 5.08 
about 19.17
Based on a normal probability distribution, the odds of Sophia Genetics to move above the current price in 90 days from now is about 19.17 (This Sophia Genetics SA probability density function shows the probability of Sophia Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Sophia Genetics has a beta of 0.38. This usually implies as returns on the market go up, Sophia Genetics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Sophia Genetics SA will be expected to be much smaller as well. Additionally Sophia Genetics SA has an alpha of 0.4718, implying that it can generate a 0.47 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Sophia Genetics Price Density   
       Price  

Predictive Modules for Sophia Genetics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Sophia Genetics SA. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
1.135.099.05
Details
Intrinsic
Valuation
LowRealHigh
2.326.2810.24
Details
Naive
Forecast
LowNextHigh
0.814.778.73
Details
6 Analysts
Consensus
LowTargetHigh
6.987.678.51
Details

Sophia Genetics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Sophia Genetics is not an exception. The market had few large corrections towards the Sophia Genetics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Sophia Genetics SA, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Sophia Genetics within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.47
β
Beta against Dow Jones0.38
σ
Overall volatility
0.39
Ir
Information ratio 0.1

Sophia Genetics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Sophia Genetics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Sophia Genetics SA can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Sophia Genetics SA had very high historical volatility over the last 90 days
The company reported the previous year's revenue of 65.17 M. Net Loss for the year was (61.27 M) with profit before overhead, payroll, taxes, and interest of 49.49 M.
Sophia Genetics SA currently holds about 216.61 M in cash with (42.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.38.
Sophia Genetics SA has a frail financial position based on the latest SEC disclosures
Latest headline from news.google.com: SOPH Guggenheim Raises Price Target While Maintaining Buy Ratin - GuruFocus

Sophia Genetics Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Sophia Stock often depends not only on the future outlook of the current and potential Sophia Genetics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Sophia Genetics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding65.8 M
Cash And Short Term Investments80.2 M

Sophia Genetics Technical Analysis

Sophia Genetics' future price can be derived by breaking down and analyzing its technical indicators over time. Sophia Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Sophia Genetics SA. In general, you should focus on analyzing Sophia Stock price patterns and their correlations with different microeconomic environments and drivers.

Sophia Genetics Predictive Forecast Models

Sophia Genetics' time-series forecasting models is one of many Sophia Genetics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Sophia Genetics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Sophia Genetics SA

Checking the ongoing alerts about Sophia Genetics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Sophia Genetics SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Sophia Genetics SA had very high historical volatility over the last 90 days
The company reported the previous year's revenue of 65.17 M. Net Loss for the year was (61.27 M) with profit before overhead, payroll, taxes, and interest of 49.49 M.
Sophia Genetics SA currently holds about 216.61 M in cash with (42.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.38.
Sophia Genetics SA has a frail financial position based on the latest SEC disclosures
Latest headline from news.google.com: SOPH Guggenheim Raises Price Target While Maintaining Buy Ratin - GuruFocus
When determining whether Sophia Genetics SA offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sophia Genetics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sophia Genetics Sa Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sophia Genetics Sa Stock:
Is there potential for Health Care Equipment & Supplies market expansion? Will Sophia introduce new products? Factors like these will boost the valuation of Sophia Genetics. If investors know Sophia will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Sophia Genetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.12)
Revenue Per Share
1.092
Quarterly Revenue Growth
0.228
Return On Assets
(0.26)
Return On Equity
(0.86)
The market value of Sophia Genetics SA is measured differently than its book value, which is the value of Sophia that is recorded on the company's balance sheet. Investors also form their own opinion of Sophia Genetics' value that differs from its market value or its book value, called intrinsic value, which is Sophia Genetics' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Sophia Genetics' market value can be influenced by many factors that don't directly affect Sophia Genetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sophia Genetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sophia Genetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Sophia Genetics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.